WHO Consultation on Public Health and Animal Transmissible Spongiform Encyphalopathies: Epidemiology, Risk and research Requirements: Geneva, Switzerland, 1 - 3 December 1999
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Tagungsbericht Buch |
| Sprache: | English |
| Veröffentlicht: |
Geneva
2000
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | 51 S. |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV013568073 | ||
| 003 | DE-604 | ||
| 005 | 20010608 | ||
| 007 | t | ||
| 008 | 010205s2000 sz |||| 10||| eng d | ||
| 035 | |a (OCoLC)633391824 | ||
| 035 | |a (DE-599)BVBBV013568073 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 044 | |a sz |c CH | ||
| 049 | |a DE-M49 | ||
| 084 | |a VET 590f |2 stub | ||
| 084 | |a MED 602f |2 stub | ||
| 111 | 2 | |a Consultation on Public Health and Animal Transmissible Spongiform Encephalopathies |d 1999 |c Genf |j Verfasser |0 (DE-588)1404193-5 |4 aut | |
| 245 | 1 | 0 | |a WHO Consultation on Public Health and Animal Transmissible Spongiform Encyphalopathies: Epidemiology, Risk and research Requirements |b Geneva, Switzerland, 1 - 3 December 1999 |c World Health Organization, Department of Communicable Disease Surveillance and Response |
| 264 | 1 | |a Geneva |c 2000 | |
| 300 | |a 51 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 0 | 7 | |a Jakob-Creutzfeldt-Syndrom |0 (DE-588)4220958-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Risikoanalyse |0 (DE-588)4137042-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Traberkrankheit |0 (DE-588)4227952-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Übertragung |0 (DE-588)4139489-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Epidemiologie |0 (DE-588)4015016-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gattung |0 (DE-588)4156088-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a BSE |0 (DE-588)4345150-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Forschungspolitik |0 (DE-588)4125050-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Spongiöse subakute Encephalopathie |0 (DE-588)4277502-4 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Spongiöse subakute Encephalopathie |0 (DE-588)4277502-4 |D s |
| 689 | 0 | 1 | |a BSE |0 (DE-588)4345150-0 |D s |
| 689 | 0 | 2 | |a Traberkrankheit |0 (DE-588)4227952-5 |D s |
| 689 | 0 | 3 | |a Jakob-Creutzfeldt-Syndrom |0 (DE-588)4220958-4 |D s |
| 689 | 0 | 4 | |a Epidemiologie |0 (DE-588)4015016-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Spongiöse subakute Encephalopathie |0 (DE-588)4277502-4 |D s |
| 689 | 1 | 1 | |a BSE |0 (DE-588)4345150-0 |D s |
| 689 | 1 | 2 | |a Traberkrankheit |0 (DE-588)4227952-5 |D s |
| 689 | 1 | 3 | |a Jakob-Creutzfeldt-Syndrom |0 (DE-588)4220958-4 |D s |
| 689 | 1 | 4 | |a Übertragung |0 (DE-588)4139489-6 |D s |
| 689 | 1 | 5 | |a Gattung |0 (DE-588)4156088-7 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Spongiöse subakute Encephalopathie |0 (DE-588)4277502-4 |D s |
| 689 | 2 | 1 | |a BSE |0 (DE-588)4345150-0 |D s |
| 689 | 2 | 2 | |a Traberkrankheit |0 (DE-588)4227952-5 |D s |
| 689 | 2 | 3 | |a Jakob-Creutzfeldt-Syndrom |0 (DE-588)4220958-4 |D s |
| 689 | 2 | 4 | |a Risikoanalyse |0 (DE-588)4137042-9 |D s |
| 689 | 2 | 5 | |a Forschungspolitik |0 (DE-588)4125050-3 |D s |
| 689 | 2 | |5 DE-604 | |
| 856 | 4 | 2 | |m Digitalisierung TU Muenchen |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009267142&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-009267142 | ||
Datensatz im Suchindex
| _version_ | 1804128369518837760 |
|---|---|
| adam_text | Contents
Opening
..............................................................................................................................1
Section
1.
Background
..........................................................................................................4
1.1
Trends in
Bovine Spongiforra Encephalopathy
..........................................................4
1.2 Trends
in variant
Creutzfeldt
Jakob Disease
..............................................................5
Section
2.
Bovine Spongiform Encephalopathy
in Sheep
.....................................................6
2.1
Transmission
of
Bovine Spongiform Encephalopathy
into sheep: Experimental
evidence and ongoing work in the United Kingdom
...............................................6
2.2
Estimating the epidemiology of Bovine Spongiform Encephalopathy in sheep
........7
2.3
France: Status report on investigations of Bovine Spongiform Encephalopathy in
sheep
........................................................................................................................8
2.4
Netherlands: Status report on investigations of Bovine Spongiform Encephalopathy
in sheep
....................................................................................................................8
2.5
Spongiform Encephalopathy Advisory Committee
-
Risk assessment of Bovine
Spongiform Encephalopathy in sheep
......................................................................9
2.6
European Union
-
Risk assessment of Bovine Spongiform Encephalopathy in
sheep
......................................................................................................................10
2.7
Office International
des
Epizooties
-
Measures relating to BSE
............................14
Section
3.
Scrapie Elimination
............................................................................................15
3.1
Principles, practice and experience of scrapie elimination
.......................................15
3.2
Transmissible Spongiform Encephalopathies in sheep
-
Surveillance
programmes
............................................................................................................16
3.3
Breeding scrapie resistant sheep: The genetics of Transmissible Spongiform
Encephalopathies in sheep
.....................................................................................16
3.4
Industry and scrapie elimination: Perspective of the Scrapie Information Group....
17
3.5
Animal vaccine-related Transmissible Spongiform Encephalopathy risks: Scrapie
outbreak in Italy
.....................................................................................................18
Section
4.
Chronic Wasting Disease
...................................................................................18
4.1
Epidemiology of Chronic Wasting Disease
..............................................................18
4.2
Diagnosis and pathogenesis of Chronic Wasting Disease
........................................20
4.3
Assessing
interspecies
Transmissible Spongiform Encephalopathy transmission
using the cell-free conversion assay
.......................................................................21
4.4
Centers for Disease and Control and Prevention investigations relating to Chronic
Wasting Disease exposures
....................................................................................22
Section
5.
Feline Spongiform Encephalopathy
...................................................................22
5.1
Pathology and epidemiology of Feline Spongiform Encephalopathy
......................22
Section
6.
Transmissible Spongiform Encephalopathies in Other Species
.........................24
6.1
Transmissible Spongiform Encephalopathies in captive wild bovids and felids
......24
6.2
The implications to humans of zoo primates infected with Bovine Spongiform
Encephalopathy
......................................................................................................25
6.3
Are there prion diseases offish?
...............................................................................25
6.4
The case for the zoonotic origins of
Creutzfeldt-
Jakob Disease
..............................26
Section
7.
Evaluation
of
Animal
Transmissible
Spongiform Encephalopathy Zoonotic
Potential
..............................................................................................................27
7.1
Diagnostic tests
for Transmissible
Spongiform Encephalopathies: Status and update
of the European
Union initiative
.............................................................................27
7.2
Potential of
diagnostic tests
to distinguish between Bovine Spongiform
Encepathology and scrapie
......................................................................................27
7.3
Diagnostic protocols for Transmissible Spongiform Encephalopathies: Rationales
and their applications
...............................................................................................28
7.4
Diagnostic tests and standardized reagents: WHO initiative
....................................29
7.5
The Rendering Industry
-
Current sourcing and current product uses in animals....
29
7.6
Could vaccines prepared from animal brain tissue pose a risk of transmission
of Transmissible Spongiform Encephalopathies to humans?
..................................33
7.7
Surveillance and eradication of animal diseases: Principles from human
diseases
....................................................................................................................34
Section
8.
Recommendations
.............................................................................................36
Section
1 :
Background on new variant
Creutzfeldt-
Jakob Disease and Bovine
Spongiform Encephalopathy
.................................................................................36
Section
2:
Bovine Spongiform Encephalopathy in small ruminants such as sheep and
goats
.......................................................................................................................36
Section
3:
Scrapie control programmes
...................................................................................38
Section
4:
Chronic Wasting Disease
........................................................................................39
Sections
5
and 6:Feline Spongiform Encephalopathies and Transmissible
Spongiform Encephalopathies in other species
.............................................40
Section
7:
Evaluation of animal Transmissible Spongiform Encephalopathy zoonotic
potential
.................................................................................................................41
Annex
1
Agenda
..............................................................................................43
Annex
2
List of Participants
............................................................................47
|
| any_adam_object | 1 |
| author_corporate | Consultation on Public Health and Animal Transmissible Spongiform Encephalopathies Genf |
| author_corporate_role | aut |
| author_facet | Consultation on Public Health and Animal Transmissible Spongiform Encephalopathies Genf |
| author_sort | Consultation on Public Health and Animal Transmissible Spongiform Encephalopathies Genf |
| building | Verbundindex |
| bvnumber | BV013568073 |
| classification_tum | VET 590f MED 602f |
| ctrlnum | (OCoLC)633391824 (DE-599)BVBBV013568073 |
| discipline | Veterinärmedizin Medizin |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02968nam a2200649 c 4500</leader><controlfield tag="001">BV013568073</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20010608 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">010205s2000 sz |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)633391824</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013568073</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">sz</subfield><subfield code="c">CH</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M49</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VET 590f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 602f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">Consultation on Public Health and Animal Transmissible Spongiform Encephalopathies</subfield><subfield code="d">1999</subfield><subfield code="c">Genf</subfield><subfield code="j">Verfasser</subfield><subfield code="0">(DE-588)1404193-5</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">WHO Consultation on Public Health and Animal Transmissible Spongiform Encyphalopathies: Epidemiology, Risk and research Requirements</subfield><subfield code="b">Geneva, Switzerland, 1 - 3 December 1999</subfield><subfield code="c">World Health Organization, Department of Communicable Disease Surveillance and Response</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Geneva</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">51 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Jakob-Creutzfeldt-Syndrom</subfield><subfield code="0">(DE-588)4220958-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Risikoanalyse</subfield><subfield code="0">(DE-588)4137042-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Traberkrankheit</subfield><subfield code="0">(DE-588)4227952-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Übertragung</subfield><subfield code="0">(DE-588)4139489-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Epidemiologie</subfield><subfield code="0">(DE-588)4015016-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gattung</subfield><subfield code="0">(DE-588)4156088-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">BSE</subfield><subfield code="0">(DE-588)4345150-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Forschungspolitik</subfield><subfield code="0">(DE-588)4125050-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Spongiöse subakute Encephalopathie</subfield><subfield code="0">(DE-588)4277502-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Spongiöse subakute Encephalopathie</subfield><subfield code="0">(DE-588)4277502-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">BSE</subfield><subfield code="0">(DE-588)4345150-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Traberkrankheit</subfield><subfield code="0">(DE-588)4227952-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Jakob-Creutzfeldt-Syndrom</subfield><subfield code="0">(DE-588)4220958-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Epidemiologie</subfield><subfield code="0">(DE-588)4015016-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Spongiöse subakute Encephalopathie</subfield><subfield code="0">(DE-588)4277502-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">BSE</subfield><subfield code="0">(DE-588)4345150-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Traberkrankheit</subfield><subfield code="0">(DE-588)4227952-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Jakob-Creutzfeldt-Syndrom</subfield><subfield code="0">(DE-588)4220958-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="4"><subfield code="a">Übertragung</subfield><subfield code="0">(DE-588)4139489-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="5"><subfield code="a">Gattung</subfield><subfield code="0">(DE-588)4156088-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Spongiöse subakute Encephalopathie</subfield><subfield code="0">(DE-588)4277502-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">BSE</subfield><subfield code="0">(DE-588)4345150-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Traberkrankheit</subfield><subfield code="0">(DE-588)4227952-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="3"><subfield code="a">Jakob-Creutzfeldt-Syndrom</subfield><subfield code="0">(DE-588)4220958-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="4"><subfield code="a">Risikoanalyse</subfield><subfield code="0">(DE-588)4137042-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="5"><subfield code="a">Forschungspolitik</subfield><subfield code="0">(DE-588)4125050-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung TU Muenchen</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009267142&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009267142</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV013568073 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T18:48:09Z |
| institution | BVB |
| institution_GND | (DE-588)1404193-5 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009267142 |
| oclc_num | 633391824 |
| open_access_boolean | |
| owner | DE-M49 DE-BY-TUM |
| owner_facet | DE-M49 DE-BY-TUM |
| physical | 51 S. |
| publishDate | 2000 |
| publishDateSearch | 2000 |
| publishDateSort | 2000 |
| record_format | marc |
| spelling | Consultation on Public Health and Animal Transmissible Spongiform Encephalopathies 1999 Genf Verfasser (DE-588)1404193-5 aut WHO Consultation on Public Health and Animal Transmissible Spongiform Encyphalopathies: Epidemiology, Risk and research Requirements Geneva, Switzerland, 1 - 3 December 1999 World Health Organization, Department of Communicable Disease Surveillance and Response Geneva 2000 51 S. txt rdacontent n rdamedia nc rdacarrier Jakob-Creutzfeldt-Syndrom (DE-588)4220958-4 gnd rswk-swf Risikoanalyse (DE-588)4137042-9 gnd rswk-swf Traberkrankheit (DE-588)4227952-5 gnd rswk-swf Übertragung (DE-588)4139489-6 gnd rswk-swf Epidemiologie (DE-588)4015016-1 gnd rswk-swf Gattung (DE-588)4156088-7 gnd rswk-swf BSE (DE-588)4345150-0 gnd rswk-swf Forschungspolitik (DE-588)4125050-3 gnd rswk-swf Spongiöse subakute Encephalopathie (DE-588)4277502-4 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Spongiöse subakute Encephalopathie (DE-588)4277502-4 s BSE (DE-588)4345150-0 s Traberkrankheit (DE-588)4227952-5 s Jakob-Creutzfeldt-Syndrom (DE-588)4220958-4 s Epidemiologie (DE-588)4015016-1 s DE-604 Übertragung (DE-588)4139489-6 s Gattung (DE-588)4156088-7 s Risikoanalyse (DE-588)4137042-9 s Forschungspolitik (DE-588)4125050-3 s Digitalisierung TU Muenchen application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009267142&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | WHO Consultation on Public Health and Animal Transmissible Spongiform Encyphalopathies: Epidemiology, Risk and research Requirements Geneva, Switzerland, 1 - 3 December 1999 Jakob-Creutzfeldt-Syndrom (DE-588)4220958-4 gnd Risikoanalyse (DE-588)4137042-9 gnd Traberkrankheit (DE-588)4227952-5 gnd Übertragung (DE-588)4139489-6 gnd Epidemiologie (DE-588)4015016-1 gnd Gattung (DE-588)4156088-7 gnd BSE (DE-588)4345150-0 gnd Forschungspolitik (DE-588)4125050-3 gnd Spongiöse subakute Encephalopathie (DE-588)4277502-4 gnd |
| subject_GND | (DE-588)4220958-4 (DE-588)4137042-9 (DE-588)4227952-5 (DE-588)4139489-6 (DE-588)4015016-1 (DE-588)4156088-7 (DE-588)4345150-0 (DE-588)4125050-3 (DE-588)4277502-4 (DE-588)1071861417 |
| title | WHO Consultation on Public Health and Animal Transmissible Spongiform Encyphalopathies: Epidemiology, Risk and research Requirements Geneva, Switzerland, 1 - 3 December 1999 |
| title_auth | WHO Consultation on Public Health and Animal Transmissible Spongiform Encyphalopathies: Epidemiology, Risk and research Requirements Geneva, Switzerland, 1 - 3 December 1999 |
| title_exact_search | WHO Consultation on Public Health and Animal Transmissible Spongiform Encyphalopathies: Epidemiology, Risk and research Requirements Geneva, Switzerland, 1 - 3 December 1999 |
| title_full | WHO Consultation on Public Health and Animal Transmissible Spongiform Encyphalopathies: Epidemiology, Risk and research Requirements Geneva, Switzerland, 1 - 3 December 1999 World Health Organization, Department of Communicable Disease Surveillance and Response |
| title_fullStr | WHO Consultation on Public Health and Animal Transmissible Spongiform Encyphalopathies: Epidemiology, Risk and research Requirements Geneva, Switzerland, 1 - 3 December 1999 World Health Organization, Department of Communicable Disease Surveillance and Response |
| title_full_unstemmed | WHO Consultation on Public Health and Animal Transmissible Spongiform Encyphalopathies: Epidemiology, Risk and research Requirements Geneva, Switzerland, 1 - 3 December 1999 World Health Organization, Department of Communicable Disease Surveillance and Response |
| title_short | WHO Consultation on Public Health and Animal Transmissible Spongiform Encyphalopathies: Epidemiology, Risk and research Requirements |
| title_sort | who consultation on public health and animal transmissible spongiform encyphalopathies epidemiology risk and research requirements geneva switzerland 1 3 december 1999 |
| title_sub | Geneva, Switzerland, 1 - 3 December 1999 |
| topic | Jakob-Creutzfeldt-Syndrom (DE-588)4220958-4 gnd Risikoanalyse (DE-588)4137042-9 gnd Traberkrankheit (DE-588)4227952-5 gnd Übertragung (DE-588)4139489-6 gnd Epidemiologie (DE-588)4015016-1 gnd Gattung (DE-588)4156088-7 gnd BSE (DE-588)4345150-0 gnd Forschungspolitik (DE-588)4125050-3 gnd Spongiöse subakute Encephalopathie (DE-588)4277502-4 gnd |
| topic_facet | Jakob-Creutzfeldt-Syndrom Risikoanalyse Traberkrankheit Übertragung Epidemiologie Gattung BSE Forschungspolitik Spongiöse subakute Encephalopathie Konferenzschrift |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009267142&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT consultationonpublichealthandanimaltransmissiblespongiformencephalopathiesgenf whoconsultationonpublichealthandanimaltransmissiblespongiformencyphalopathiesepidemiologyriskandresearchrequirementsgenevaswitzerland13december1999 |